Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Summer Sessions 7: Dr. Randall Schatzman & The New Fundraising Norm

    Summer Sessions 7: Dr. Randall Schatzman & The New Fundraising Norm

    FromBusiness Of Biotech

    Start listeningView podcast show

    Summer Sessions 7: Dr. Randall Schatzman & The New Fundraising Norm

    FromBusiness Of Biotech

    ratings:
    Length:
    40 minutes
    Released:
    Aug 24, 2020
    Format:
    Podcast episode

    Description

    Dr. Randy Schatzman, CEO at Bolt Biotherapeutics, discusses his company's adjustment to pandemic disruption on the fundraising trail. He walks us through the remote-fundraising strategy that landed Bolt's recent $93.5 million Series C financing round, and how the company is moving towards an IPO in spite of market, civil, and political tumult.
    Released:
    Aug 24, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, formerly GE Healthcare Life Sciences.